KLTO · Categories · Form 4
KLTO - SEC Form 4 insider transactions
Klotho Neurosciences Inc. (KLTO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for KLTO
- Chief Financial Officer Leblanc Jeff was granted 2,500,000 shares, increasing direct ownership by 272% to 3,420,342 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director El-Dada Riad Hussein was granted 350,000 shares (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Zentman Samuel M was granted 350,000 shares, increasing direct ownership by 48% to 1,086,440 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Hirschman Shalom was granted 350,000 shares, increasing direct ownership by 63% to 908,873 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Mcgarity Jon was granted 350,000 shares, increasing direct ownership by 571% to 411,277 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Chief Executive Officer Sinkule Joseph was granted 2,500,000 shares, increasing direct ownership by 65% to 6,346,700 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- SEC Form 4 filed by Director Mcgarity Jon4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- SEC Form 4 filed by Director Zentman Samuel M4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- SEC Form 4 filed by Director El-Dada Riad Hussein4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Chief Executive Officer Sinkule Joseph acquired 400,000 shares, increasing direct ownership by 9% to 4,846,700 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Chief Financial Officer Leblanc Jeff was granted 200,000 shares, increasing direct ownership by 28% to 920,342 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Chief Executive Officer Sinkule Joseph disposed of 2,000,000 shares and was granted 537,180 shares, decreasing direct ownership by 25% to 4,446,700 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Zentman Samuel M was granted 153,494 shares (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Hirschman Shalom was granted 70,149 shares, increasing direct ownership by 14% to 558,873 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Chief Financial Officer Leblanc Jeff was granted 156,199 shares, increasing direct ownership by 28% to 720,342 units (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- SEC Form 4 filed by Director El-Dada Riad Hussein4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
- Director Mcgarity Jon was granted 14,641 shares (SEC Form 4)4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)